YONGIN, South Korea, Aug. 21, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that it has revealed the delivery mechanism of Hunterase (idursulfase beta), a recombinant enzyme replacement therapy for Hunter syndrome (MPS II)....
Hence then, the article about gc biopharma s study on hunterase lysosomal delivery mechanism published in scie indexed journal was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( GC Biopharma's Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE-Indexed Journal )
Also on site :
- Arden University and Google Cloud Form Strategic Partnership to Ensure Development of Job-Ready, AI-Native Graduates
- Exclusivo: ordenan a ICE aumentar las detenciones diarias de inmigrantes a pesar del malestar del Partido Republicano
- ‘Below’ Review: Josh Hartnett Battles a Sea Creature in Netflix’s Likably Silly Newfoundland-Set Thriller